63 related articles for article (PubMed ID: 28550415)
1. Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study.
Ma X; Guo W; Yang S; Zhu X; Xiang J; Li H
Dis Markers; 2015; 2015():814670. PubMed ID: 26265795
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
Yun S; Han YS; Lee JH; Kim S; Lee SH
Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
[TBL] [Abstract][Full Text] [Related]
3. GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma.
Zhang X; Wu R; Tian C; Wang W; Zhou L; Guo T; Yu J; Wu C; Shen Y; Liu X; Yu R
Cell Death Discov; 2022 Mar; 8(1):133. PubMed ID: 35347123
[TBL] [Abstract][Full Text] [Related]
4. GRP78 overexpression as an unfavorable outcome in glioma patients.
Bao L; Luo Q; Zhang J; Lao Z
Int J Clin Exp Pathol; 2018; 11(1):420-426. PubMed ID: 31938127
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma.
Imai H; Shimizu K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Tanaka S; Fujita A; Kogure Y; Seki Y; Mogi A; Oyama T; Minato K; Asao T; Kaira K
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31653009
[TBL] [Abstract][Full Text] [Related]
6. Is GRP78 (Glucose-regulated protein 78) a prognostic biomarker in differents types of cancer? A systematic review and meta-analysis.
Dos Santos NS; Gonçalves DR; Balbinot B; Visioli F
Pathol Res Pract; 2023 Feb; 242():154301. PubMed ID: 36610326
[TBL] [Abstract][Full Text] [Related]
7. Roles of Grp78 in Female Mammalian Reproduction.
Zhang C
Adv Anat Embryol Cell Biol; 2017; 222():129-155. PubMed ID: 28389754
[TBL] [Abstract][Full Text] [Related]
8. High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma.
Miura Y; Kaira K; Sakurai R; Imai H; Tomizawa Y; Sunaga N; Minato K; Hisada T; Oyama T; Yamada M
Int J Clin Oncol; 2017 Oct; 22(5):872-879. PubMed ID: 28550415
[TBL] [Abstract][Full Text] [Related]
9. Decreasing expression of glucose-regulated protein GRP78/BiP as a significant prognostic predictor in patients with advanced laryngeal squamous cell carcinoma.
Kaira K; Toyoda M; Shimizu A; Imai H; Sakakura K; Nikkuni O; Suzuki M; Iijima M; Asao T; Chikamatsu K
Head Neck; 2016 Oct; 38(10):1539-44. PubMed ID: 27312568
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Pathological Significance of ER Stress Marker (BiP/GRP78 and PERK) Expression in Malignant Melanoma.
Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
Pathol Oncol Res; 2017 Jan; 23(1):111-116. PubMed ID: 27502501
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of GRP78/BiP expression in patients with Stage III/IV hypopharyngeal squamous cell carcinoma.
Kaira K; Toyoda M; Shimizu A; Imai H; Sakakura K; Nikkuni O; Suzuki M; Iijima M; Asao T; Chikamatsu K
Neoplasma; 2016; 63(3):477-83. PubMed ID: 26952514
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma.
Ogawa H; Kaira K; Takahashi K; Shimizu A; Altan B; Yoshinari D; Asao T; Oyama T
Cancer Biomark; 2017 Sep; 20(3):273-281. PubMed ID: 28854502
[TBL] [Abstract][Full Text] [Related]
13. Expression of ER stress markers (GRP78/BiP and PERK) in patients with tongue cancer.
Kaira K; Toyoda M; Shimizu A; Mori K; Shino M; Sakakura K; Takayasu Y; Takahashi K; Oyama T; Asao T; Chikamatsu K
Neoplasma; 2016; 63(4):588-94. PubMed ID: 27268922
[TBL] [Abstract][Full Text] [Related]
14. Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.
Miura Y; Kaira K; Sakurai R; Imai H; Tomizawa Y; Sunaga N; Minato K; Hisada T; Oyama T; Yamada M
Oncol Lett; 2017 Aug; 14(2):2369-2378. PubMed ID: 28789453
[TBL] [Abstract][Full Text] [Related]
15. Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.
Cerezo M; Lehraiki A; Millet A; Rouaud F; Plaisant M; Jaune E; Botton T; Ronco C; Abbe P; Amdouni H; Passeron T; Hofman V; Mograbi B; Dabert-Gay AS; Debayle D; Alcor D; Rabhi N; Annicotte JS; Héliot L; Gonzalez-Pisfil M; Robert C; Moréra S; Vigouroux A; Gual P; Ali MMU; Bertolotto C; Hofman P; Ballotti R; Benhida R; Rocchi S
Cancer Cell; 2016 Jul; 30(1):183. PubMed ID: 27479035
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
